نتایج جستجو برای: attenuated live vaccine

تعداد نتایج: 253717  

2017
Herve Caspard Robert P Wise Amy Steffey Robert S Brody

OBJECTIVES To estimate the proportion of live-attenuated influenza vaccine (LAIV) doses administered beyond expiry date in children and adolescents during influenza seasons 2013-2014 and 2014-2015 in the UK. DESIGN This was a retrospective cohort study. Two cohorts of children and adolescents who received LAIV from 1 September 2013 to 31 March 2014 and from 1 September 2014 to 31 March 2015 a...

Journal: :vaccine research 0
amin daemi molecular immunology and vaccine research laboratory, pasteur institute of iran, tehran, iran, department of hepatitis and aids, pasteur institute of iran, tehran, iran sahar hosseinzadeh molecular immunology and vaccine research laboratory, pasteur institute of iran, tehran, iran, department of hepatitis and aids, pasteur institute of iran, tehran, iran azam bolhassani department of hepatitis and aids, pasteur institute of iran, tehran, iran elnaz agi department of hepatitis and aids, pasteur institute of iran, tehran, iran

introduction: vaccinology provides promising approaches for the control of various infectious diseases. among different strategies, dna vaccines offer attractive research opportunities for development of vaccines for induction of antigen-specific immunity owing to their stability, simplicity of delivery, safety and cost effectiveness. however, there is a need to increase their potency by the us...

2018
Jerold Jeyaratnam Nienke M. ter Haar Helen J. Lachmann Ozgur Kasapcopur Amanda K. Ombrello Donato Rigante Fatma Dedeoglu Ezgi H. Baris Sebastiaan J. Vastert Nico M. Wulffraat Joost Frenkel

BACKGROUND Withholding live-attenuated vaccines in patients using interleukin (IL)-1 or IL-6 blocking agents is recommended by guidelines for both pediatric and adult rheumatic diseases, since there is a risk of infection in an immune suppressed host. However, this has never been studied. This retrospective, multicenter survey aimed to evaluate the safety of live-attenuated vaccines in patients...

Journal: :Pediatrics 2007
Patrick Jean-Philippe Abigail Freedman Mary Wu Chang Sharon P Steinberg Anne A Gershon Philip S LaRussa William Borkowsky

In March 1995, the US Food and Drug Administration approved a live attenuated varicella vaccine for use in healthy children 12 months to 12 years old. We report here an 18-month-old girl with cell-mediated immunodeficiency who developed a severe vaccine-associated rash and clinical evidence of vaccine-associated pneumonia 1 month after inadvertent receipt of varicella vaccine.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید